Nimotuzumab
CAS No. 828933-51-3
Nimotuzumab ( —— )
Catalog No. M22154 CAS No. 828933-51-3
Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
Biological Information
-
Product NameNimotuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionNimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
-
DescriptionNimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number828933-51-3
-
Formula Weight148 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li J. Roovers, et al.Time profile of nimotuzumab for enhancing radiosensitivity of the Eca109 cell line.Oncol Lett.2019 Mar;17(3):2763-2769.
molnova catalog
related products
-
Sanguinarine chlorid...
Sanguinarine-containing mouthwashes are marketed as anti-plaque and anti-malodor.
-
Canertinib dihydroch...
A potent, irreversible, orally available pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 7.5 nM and 9.0 nM in autophosphorylation assay.
-
CGP77675
CGP77675 is a potent and selective inhibitor of Src family kinase with IC50s of 5-20 and 40 nM for the phosphorylation of peptide substrates and autophosphorylation of purified Src. CGP77675 exhibits anticancer activity.